Combined Low Dose Rate Brachytherapy and External Beam Radiation Therapy for Intermediate-Risk Prostate Cancer.

Journal: Journal of medical imaging and radiation sciences
Published Date: Nov 8, 2018

Abstract

INTRODUCTION: This is a retrospective study conducted to report the tumor control and late toxicity outcomes of patients with intermediate-risk prostate cancer undergoing combination external beam radiation therapy and low dose rate brachytherapy (LDR-PB).

Authors

  • Michael Chao
    Genesis Cancer Care Victoria, Ringwood, Australia; The Austin Hospital, Heidelberg, Australia; Ringwood Private Hospital, Ringwood East, Australia; University of Melbourne, Melbourne, Australia. Electronic address: Michael.Chao@genesiscare.com.
  • Daryl Lim Joon
    The Austin Hospital, Heidelberg, Australia; University of Melbourne, Melbourne, Australia.
  • Vincent Khoo
    The Austin Hospital, Heidelberg, Australia; University of Melbourne, Melbourne, Australia; Royal Marsden Hospital, London, UK.
  • Sandra Spencer
    Genesis Cancer Care Victoria, Ringwood, Australia.
  • Huong Ho
    Genesis Cancer Care Victoria, Ringwood, Australia.
  • Mario Guerrieri
    Genesis Cancer Care Victoria, Ringwood, Australia; Ringwood Private Hospital, Ringwood East, Australia.
  • Farshad Foroudi
    The Austin Hospital, Heidelberg, Australia; University of Melbourne, Melbourne, Australia.
  • Damien Bolton
    The Austin Hospital, Heidelberg, Australia; Ringwood Private Hospital, Ringwood East, Australia; University of Melbourne, Melbourne, Australia.

Keywords

External Resources

Popular Topics
Recent Journals